Does LUTETIUM LU-177 Cause Metastases to bone? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Metastases to bone have been filed in association with LUTETIUM LU-177. This represents 6.1% of all adverse event reports for LUTETIUM LU-177.
7
Reports of Metastases to bone with LUTETIUM LU-177
6.1%
of all LUTETIUM LU-177 reports
1
Deaths
4
Hospitalizations
How Dangerous Is Metastases to bone From LUTETIUM LU-177?
Of the 7 reports, 1 (14.3%) resulted in death, 4 (57.1%) required hospitalization.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUTETIUM LU-177. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LUTETIUM LU-177 Cause?
Malignant neoplasm progression (39)
Fatigue (35)
Diarrhoea (29)
Abdominal pain (19)
Asthenia (19)
Vomiting (19)
Blood pressure increased (18)
Body temperature decreased (18)
Drug ineffective (18)
Blood pressure systolic increased (17)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which LUTETIUM LU-177 Alternatives Have Lower Metastases to bone Risk?
LUTETIUM LU-177 vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
LUTETIUM LU-177 vs LUTETIUM OXODOTREOTIDE LU-177
LUTETIUM LU-177 vs LUTROPIN ALFA
LUTETIUM LU-177 vs LYMECYCLINE
LUTETIUM LU-177 vs LYRICA